Brief: ClearPoint Neuro Q4 Operating Expenses USD 13.4 Million
17/03/2026 20:05
Mar 17 (Reuters) - ClearPoint Neuro Q4 gross margin 62%. outlook FY revenue USD 52-56 million
Recent news on Clearpoint Neuro
See all newsClearpoint Neuro Inc reports results for the quarter ended June 30 - Earnings Summary
ClearPoint Neuro Q2 revenue rises 18% but misses estimates
Brief: ClearPoint Neuro Q2 Revenue USD 10.9 Million
ClearPoint Neuro Q1 revenue rises 43%, beats estimates
ClearPoint Neuro Q4 revenue rises on IRRAS acquisition